Europe Musculoskeletal (MSK) Disease Management Market, By Type (Digital Biofeedback System, Musculoskeletal-focused Digital Apps, Solutions and Others), Technology (Precision Motion Technology, Computer Vision Technology and Other Technologies), Integration Type (Phone, Tablet, Computer and Others), Modality (Virtual Therapy, In-Person Therapy, Customized/Personalized Therapy and Others), Application (Pre-Surgery Applications and Post-Surgery Applications), Patient Population (Pediatrics, Adults and Geriatrics), End User (Hospitals & Clinics, Nursing Homes, Health Centers, Rehabilitation Centres, Virtual/Home Health Care Settings and Others) - Industry Trends and Forecast to 2030.
Europe Musculoskeletal (MSK) Disease Management Market Analysis and Insights
The increasing demand for technological advancements in the diagnosis of MSK diseases, rising awareness about MSK diseases, growing prevalence of Rheumatoid Arthritis (RA), and increasing cases of bone fractures are the factors expected to drive the market growth.
On the other hand, strategic initiatives by market players, product development, use of telemedicine in MSK disease management, and increased use of MDAs and home healthcare for MSK disease management may act as an opportunity for market growth.
However, the high cost of diagnosis and treatment of orthopedic diseases and rise in use of heavy-duty drugs in treating MSK pain are expected to restrain the market growth.
The rising demand for use of MSK disease management in drug development and design is expected to drive market growth in Europe. Data Bridge Market Research analyzes that the Europe musculoskeletal (MSK) disease management market will grow at a CAGR of 22.2%, during the forecast period of 2023 to 2030.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Year
|
2021 (Customizable to 2023 - 2030)
|
|
Quantitative Units
|
Revenue in USD Million, Pricing in USD
|
|
Segments Covered
|
By Type (Digital Biofeedback System, Musculoskeletal-focused Digital Apps, Solutions and Others), Technology (Precision Motion Technology, Computer Vision Technology and Other Technologies), Integration Type (Phone, Tablet, Computer and Others), Modality (Virtual Therapy, In-Person Therapy, Customized/Personalized Therapy and Others), Application (Pre-Surgery Applications and Post-Surgery Applications), Patient Population (Pediatrics, Adults and Geriatrics), End User (Hospitals & Clinics, Nursing Homes, Health Centers, Rehabilitation Centres, Virtual/Home Health Care Settings and Others)
|
|
Countries Covered
|
Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Denmark, Switzerland, Sweden, Poland, Norway, Finland and rest of Europe
|
|
Market Players Covered
|
RecoveryOne, Kiio, Omada Health Inc., DarioHealth Corp., IncludeHealth, kaia health, IMC., Wellness Coaches USA, LLC, Sparta Science, Movement RX, Phzio, Airrosti Rehab Center, LLC, SimpleTherapy, Inc., Hinge Health, Inc., Sword Health, Inc., SPRITE HEALTH and Limber Health, Inc. among others
|
Market Definition
Musculoskeletal (MSK) disease or impairments comprise more than 150 different diseases or conditions, which internally affect the human system and are characterized by deficiencies in the muscles, bones, joints and adjacent connective tissues, which lead to lifelong hindrances in functioning and participation. The conditions are characterized by pain, limited gait movement and dexterity thereby, reducing people’s aptitude to work and participate in society.
The management of MSK diseases involves consultation with a physician, integrated with telemedicine, which is the use of Digital Biofeedback Systems (DBSs), MDAs and therapies. Physical activity and weight management programs are also important self-management activities for persons with arthritis. Virtual therapy or remote consultation entails a holistic approach with the implementation of video conference and phone consultations in MSK practice.
- In the coming future, important decisions related to MSK disease management on physical movement and post-surgery applications will be made by individuals who not only understand telemedicine and virtual technology but, can also use MSK disease management tools and the knowledge they release to develop hypotheses and identify quality targets.
Europe Musculoskeletal (MSK) Disease Management Market Dynamics
Drivers
- Technological advances in the diagnosis of musculoskeletal disorders (MSDS)
Musculoskeletal (MSK) diseases are injuries and disorders that affect the movement of the human body in the MSK system, such as muscles, ligaments, nerves, tendons, cartilage and discs. Some of the common MSK conditions are myasthenia gravis, Osteoarthritis (OA), gout, RA, back pain, osteoporosis and Systemic Lupus Erythematosus (SLE). MSK pain has various causes, for example, muscle tissue can be damaged by wear and tear during daily activities. The strain on human body parts due to sprains, car accidents, falls, jerky movements, fractures, dislocations and direct muscle blows also cause MSK pain.
- Increasing cases of bone fractures
A fracture is the medical definition of a broken bone. Fractures are usually the result of injuries such as falls, car accidents, or sports injuries. However, certain medical conditions and repetitive forces (such as running) can increase the risk of certain types of fractures. If more pressure is put on a bone than it can withstand, it will crack or break. A fracture of any size is called a fracture. If the fracture pierces the skin, it is called an open fracture (compound fracture). A stress fracture is a fracture resulting from repeated or prolonged forces against the bone. Repeated stress weakens the bone until it eventually breaks.
Opportunities
- Use of telemedicine in musculoskeletal (MSK) disease management
Telemedicine provides patients with cost-effective, quality care. Previsit planning allows appropriate implementation of telemedicine, which ensures that the patients and physicians be provided with functional telemedicine equipment. Physicians for the treatment of MSK diseases perform a structured MSK examination via telemedicine. The use of common household items enables physicians to replicate in-person clinical examination maneuvers. Home care instructions and online rehabilitation provide initial management of treatment.
- Strategic initiatives by key market players
The rise in Musculoskeletal (MSK) diseases increases the need for strategic business ideas. It includes partnership, business expansion, collaboration and other developments. In the Europe musculoskeletal (MSK) disease management market, many health agencies and market players entail initiatives that are designed to deliver returns on investments to the customers. The planned strategies allow the market players to align with the organization's functional activities to achieve set goals. It guides the company's discussions and decision-making in determining resource and budget requirements to accomplish objectives, thus increasing operational efficiency.
Restraints/Challenges
- High cost of diagnosis and treatment of orthopedic diseases
Chronic orthopedic diseases such as arthritis and bursitis affect the MSK system- most often the bones or joints. They can cause pain and dysfunction, making normal daily activities difficult. These conditions are different from orthopedic injuries, such as a dislocated shoulder or broken bone, which are often caused by sudden trauma. Unlike accidental or traumatic orthopedic injuries, chronic conditions are usually progressive, starting slowly and worsening or developing over time. They may be genetic or age-related, or they may be caused by overuse.
Some orthopedic conditions are treatable and some cannot be cured at this time but can be treated to reduce pain and improve quality of life. Accurate diagnosis and targeted treatment can help reduce problems even in progressive conditions without treatment. Treatment recommendations depend on the type and severity of your condition. Treatments range from RICE (Rest, Ice, Compression and Elevation) to major surgery.
- Rise in use of heavy-duty drugs in treating MSK pain
MSK pain is a challenging condition for patients and physicians. Many adults, regardless of age, gender, or economic status, have experienced one or more episodes of MSK pain at some point in their lives. It affects about 47% of the population. About 39% to 45% of them are long-term problems that require a doctor's consultation. Inadequately treated MSK pain can reduce the quality of life and cause serious socioeconomic problems.
Multimodal analgesia and multidisciplinary approaches are key elements in the effective treatment of MSK pain. Both pharmacological, non-pharmacological and interventional pain management are important to improve the patient's recovery, well-being and quality of life. Thus, recent guidelines recommend preventive strategies and physical tools to reduce drug use. In patients who have not responded adequately to treatment, the appropriate use of interventional pain management and other alternative techniques is critical to the safe and effective treatment of patients with chronic pain.
Post-COVID-19 Impact on Europe Musculoskeletal (MSK) Disease Management Market
During the pandemic, the symptoms of MSK disease management remain existed following recovery from COVID-19, with the most common complaints including fatigue, back pain, arthralgia, myalgia, low back pain and neck pain. The management of MSK disease increases the use of virtual therapy telemedicine and digital rehabilitation service.
In the COVID-19 pandemic environment, telehealth is feasible for healthcare providers to provide rehabilitation services for their patients with various MSK conditions. Current evidence suggests that for some MSK diseases, telehealth evaluation may be reliable, treatment may be effective and patient satisfaction may be good or better than for in-office care.
Recent Developments
- In April 2022, Airrosti Rehab Center, LLC formed a partnership with Buoy Health’s innovative healthcare marketplace. The partnership resulted to bring good value MSK care to Buoy’s more than 2 million users per month and the development of novel MSK virtual products.
- In March 2022, DarioHealth Corp. formed a contractual agreement with Sanofi U.S. The agreement focused on the acceleration of commercial growth for DarioHealth Corp. in MSK disease management digital portfolio and the development of Digital Health Solutions on the DarioHealth Corp. platform.
Europe Musculoskeletal (MSK) Disease Management Market Scope
Europe musculoskeletal (MSK) disease management market is segmented into seven notable segments based on type, technology, integration type, modality, application, patient population and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Digital Biofeedback System
- Musculoskeletal-focused Digital Apps (MDAS)
- Solutions
- Others
Based on type, the market is segmented into digital biofeedback system, musculoskeletal-focused digital apps (MDAs), solutions and others.
Technology
- Precision Motion Technology
- Computer Vision Technology
- Other Technologies
Based on technology, the market is segmented into precision motion technology, computer vision technology and other technologies.
Integration Type
- Phone
- Tablet
- Computer
- Others
Based on integration type, the market is segmented into phone, tablet, computer and others
Modality
- Virtual Therapy
- In-Person Therapy
- Customized/Personalized Therapy
- Others
Based on modality, the market is segmented into virtual therapy, in-person therapy, customized/personalized therapy and others.
Application
- Pre-Surgery Applications
- Post-Surgery Applications
Based on application, the market is segmented into pre-surgery applications and post-surgery applications.
Patient Population
- Pediatrics
- Adults
- Geriatrics
Based on patient population, the market is segmented into pediatrics, adults, and geriatrics.
End User
- Hospitals & Clinics
- Nursing Homes
- Health Centers
- Rehabilitation Centers
- Virtual/Home Health Care Settings
- Others
Based on end user, the market is segmented into hospitals & clinics, nursing homes, health centers, rehabilitation centers, virtual/home healthcare settings and others.
Europe Musculoskeletal (MSK) Disease Management Market Regional Analysis/Insights
The Europe musculoskeletal (MSK) disease management market is analyzed and market size insights and trends are provided by region, type, technology, integration type, modality, application, patient population and end user as referenced above.
The countries covered in this market report are Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Denmark, Switzerland, Sweden, Poland, Norway, Finland and rest of Europe. Germany is expected to dominate the market due to increasing initiatives by market players and the utilization of modern technological tools has increased.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact on sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Musculoskeletal (MSK) Disease Management Market Share Analysis
Europe musculoskeletal (MSK) disease management market competitive landscape provides details on the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, the Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the Europe musculoskeletal (MSK) disease management market are RecoveryOne, Kiio, Omada Health Inc., DarioHealth Corp., IncludeHealth, kaia health, IMC., Wellness Coaches USA, LLC, Sparta Science, Movement RX, Phzio, Airrosti Rehab Center, LLC, SimpleTherapy, Inc., Hinge Health, Inc., Sword Health, Inc., SPRITE HEALTH and Limber Health, Inc. among others.
SKU-